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Objectives: This review provided a conceptual framework of sample size calculations in the studies of
diagnostic test accuracy in various conditions and test outcomes.
Methods: The formulae of sample size calculations for estimation of adequate sensitivity/speciﬁcity, like-
lihood ratio and AUC as an overall index of accuracy and also for testing in single modality and comparing
two diagnostic tasks have been presented for desired conﬁdence interval.
Results: The required sample sizes were calculated and tabulated with different levels of accuracies and
marginal errors with 95% conﬁdence level for estimating and for various effect sizes with 80% power for
purpose of testing as well. The results show how sample size is varied with accuracy index and effect size
of interest.
Conclusion: This would help the clinicians when designing diagnostic test studies that an adequate sam-
ple size is chosen based on statistical principles in order to guarantee the reliability of study.
 2014 Elsevier Inc. All rights reserved.1. Introduction of certain target classiﬁcation performance, the investigators needBiomedical informatics deals with health information, its struc-
ture, acquisition and use in health care and medical practices [1]. It
includes health research, education, and health services, clinical
disciplines and health care and information systems that ranging
from theoretical model to the building and evaluation of applied
diagnostic systems [1]. A speciﬁc of its domain is the evaluation
of biomarkers and diagnostic systems for classiﬁcation of diseased
from healthy subjects to make a decision in clinical practices [1–4].
The bioinformatics markers/systems in medicine have been devel-
oped progressively during the past decades. Primarily, in order to
apply the new developed biomarkers/systems for decision in clin-
ical practices and to extract extra useful information from them,
they should be evaluated in experimental setting versus a gold
standard [4–6]. The collecting experimental data of gold standard
is often expensive and time consuming. Thus, the evaluation of
classiﬁcation performance of bioinformatics systems needs
annotated training sample since the predictive power in detection
difference between two alternative classiﬁers strongly depends on
sample size [7,8]. In estimating the diagnostic accuracy and to
obtain a desired level of statistical power to detect an effect size
for testing a single modality or a comparative study of two diag-
nostic tasks in order to know which has a greater diagnostic abilityto know the minimal sample size required for their experiments.
On the other hand, if the experiments are done on with available
samples only, the investigators need to know the power of statisti-
cal test for detection a desirable effect size in their experiments.
However, the receiver operating characteristic (ROC) analysis
used in diagnostic medicine for continuous biomarkers in classiﬁ-
cation is rather complex with no single approach for analysis [3–6].
Also, there is no single measure of accuracy index in evaluating
diagnostic tools for decision support and how to estimate the sam-
ple size needed for proposed experiment. All depend on speciﬁc
application and design used in biomarker experiments. This paper
provides the sample size calculation for estimating and testing of
accuracy indexes. We included different accuracy indexes with
various types of experimental design for single diagnostic test
and comparative study of two diagnostic tasks both independent
design and matched paired design. First we brieﬂy described some
examples of relevant biomedical informatics research and then we
addressed the relevant diagnostic accuracy and the main concept
of ROC analysis in diagnostic studies and it was followed with
review of sample size calculation.
2. Examples
There are several examples of the use of ROC curve analysis in
bioinformatics medicine. A large number of computer diagnostic
systems have been developed to advise physician on patient
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model for high quality article retrieval in internal medicine [9] and
an automated text classiﬁer to detect radiology report have been
evaluated in ROC analysis [10]. In another study, several least
square vector machines for prediction of preoperative malignancy
of ovarian tumors have been developed and assessed [11]. In par-
ticular, a study was designed to evaluate a compute based algo-
rithm for diagnosis of heart disease (HD) in order to provides
useful information that can improve the cardiac diagnosis in a typ-
ical clinical setting [12]. In this study, 127 patients were entered in
two cohorts of 60 and 67 subjects. The follow up information was
available on 114 subjects with mean age of 60 years for their future
cardiac problem for ﬁnal diagnosis as gold standard. The heart dis-
ease program (HDP) algorithm was designed to assist physician in
diagnosis of HD, in particular, condition leading to homodynamic
dysfunction and heart failure. This diagnostic algorithm is based
on casual probability in term of severity of necessary causes and
the possible mechanism and the risk proﬁle. The program uses
the input data to specialize the patient proﬁle including a set of
prior probability of disease based on demographic characteristics
and risk proﬁle and to put a set of assumption and to compute
the risk score. The authors wished to compare the diagnostic per-
formance of physician alone and heard disease program (HDP)
alone with combination of physician and HDP in prediction of car-
diac problem. They used sensitivity and speciﬁcity and also ROC
curve analysis but in their ROC analysis, comparison of different
diagnostic tasks was done with descriptive method regardless of
performing statistical test. However, it is most helpful to justify
the required sample size. The question would be raised whether
the achieved sample size has power to detect a desirable effect size
of accuracy index and how to calculate the optimal sample size for
their study. In addition, the power calculation would be helpful in
interpretation of lack of difference between diagnostic tasks with
achieved sample size. These questions are also relevant for any
other ROC diagnostic studies in bioinformatics research.3. Diagnostic accuracy and classiﬁcation performance
In diagnostic studies of biomedical informatics which the test
yields dichotomized outcome (positive or negative results), the
accuracy is evaluated by sensitivity and speciﬁcity. These twomea-
sures determine the inherent ability of diagnostic test versus a
dichotomized gold standard and they are not inﬂuenced by prior
probability of disease (or prevalence) in population [2,4]. The gold
standard may be another test without errors but a more expensive
diagnostic method or invasive method. It can be the combination
of tests that may be available in clinical follow up, surgical veriﬁca-
tion, autopsy, and biopsy or by panel of experts [5,6]. The sensitivity
indicates the proportion of diseased subject with positive test result
and speciﬁcity determines the proportion of nondiseased subject
withnegative test results. The sensitivity and speciﬁcity canbe com-
bined as one-dimensional index that is called likelihood ratio (LR).
The positive LR is the ratio of probability of positive test in diseased
to nondiseased and negative LR is the ratio of probability of negative
test in diseased to nondiseased. In fact, the positive LR is the ratio of
sensitivity to 1-speciﬁcity and the negative LR is the ratio of 1-sen-
sitivity to speciﬁcity [13]. The higher value of positive LR corre-
sponds with greater information of positive test result while the
lower value of negative LR associates with more information of
negative test results. In particular, the positive and negative LR is
of greater interest in comparative studies of two diagnostic tests.
For aquantitativediagnostic testor the test results are recordedon
ordinal scale, the sensitivity and speciﬁcity varies across the different
thresholds and the sensitivity is inversely related with speciﬁcity
[2,4,14]. Then, the plot of sensitivity versus 1-speciﬁcity is calledreceiver operating characteristic (ROC) curve and the area under the
curve (AUC), as an effectivemeasure of accuracy has been considered
and it has ameaningful interpretations [15]. This curveplays a central
role in evaluating diagnostic ability of tests to discriminate the true
state of subjects and comparing two alternative diagnostic tasks
when each task is performed on the same subject [5,14–16].4. A review of sample size consideration
In evaluating the accuracy of diagnostic test in medicine, the
sample size plays an important role either for estimation or testing
of accuracy. A small sample size produces an imprecise estimate of
accuracy with wide conﬁdence interval [17] which is non-informa-
tive for decision makers in medical context. On the other hand, un-
duly large sample size is wastage of resources especially when the
new diagnostic test is expensive [18]. Unfortunately, sample sizes
calculations are rarely reported by clinical investigators for diagnos-
tic studies [19,20] and few clinicians are aware of them. Researchers
often decide about the sample size arbitrary either for their conve-
niences or from the previous literature. For example, among 40
(out of 1698 articles) published studies on non-screening diagnostic
accuracy in ﬁve higher impact factors of ophthalmology journal in
2005, only one study (2.5%) reported a prior sample size calculation
for a planned sensitivity and speciﬁcity of 80% and 95% conﬁdence
level [19]. Another report of eight journals published in 2002, 43
articles (out of 8999 articles) were non-screening on diagnostic
accuracy and two of 43 studies (5%) reported a prior calculation of
sample size but no study reported that the sample size had been cal-
culated on the base of pre-planned subgroup analysis while twenty
articles (47%) reported results for subgroup of patients [20].
In sample size calculation for estimating both sensitivity and
speciﬁcity, Buderer [21] incorporated prevalence of disease in sam-
ple size formula for sensitivity/speciﬁcity and provided the table of
sample size for sensitivity and speciﬁcity but only for precision of
10%. Malhotra and Indrayan [18] argued that the sample size with-
out considering prevalence would be adequate for sensitivity or
speciﬁcity alone but not for both while Obuchowski [22] addressed
that this is because of unknown true disease status at time of sam-
pling from target population. Charley et al. [23] have provided
monogram for estimation of sensitivity and speciﬁcity with too
many lines and curves make complexity in reading. Malhotra and
Indrayan [18] presented a table of sample size calculation based
on Borderer formula only for estimating sensitivity and speciﬁcity
but not for testing. Simel et al. [24] deal with sample size based on
desired likelihood ratios (LR) conﬁdence interval but not calculate
sample size for a wide range of marginal errors around LR. Obu-
chowski [22] also provided a review of sample size formula for a
various diagnostic accuracy but did not provide practical tables
for calculating sample sizes. Several other authors also developed
methods for sample size calculation in diagnostic medicine [25–
28] because of complexity of their methods for clinician and the
lack of availability of software their methods were not used
frequently in clinical practices. In this article, a review of the crit-
ical elements of sample size calculations for diagnostic accuracy
were addressed conceptually and the formula was driven based
on statistical principles with respect to study purpose (estimation
or testing) and accuracy of interest (sensitivity/speciﬁcity, LR and
AUC). We also calculated the required sample size for various
situations and the calculated sample size were tabulated for prac-
tical convenience of clinician in diagnostic test evaluation.5. Factors affecting on sample size for diagnostic accuracy
Based on statistical principle, as a general rule of sample size
calculation for proportions, since sensitivity (or speciﬁcity) is a
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ments are required for calculation of sample size in estimating sen-
sitivity (or speciﬁcity): (1) a pre-determined value of sensitivity (or
speciﬁcity) that is available from previous published studies or
clinical judgment; this is because the standard error of sensitivity
(or speciﬁcity) depends on its value; (2) the conﬁdence level
(1  a) for statistical judgment where a is the probability of type
I error; (3) the precision of estimates of sensitivity (or speciﬁcity)
i.e. the maximum difference between estimated sensitivity (or
speciﬁcity) and the true value. Additionally, the prevalence of dis-
ease in population is needed to be ascertained and also to be taken
into account in sample size calculation [21]. In effect, we are plan-
ning for the number of affected subjects and the number of unaf-
fected subjects separately, so we need a total number of subjects
that will make both these groups large enough. In practice usually
it is the sensitivity, not the speciﬁcity that determines the total
number of subjects to be used. When the true status or condition
is known before undergoing subjects into new diagnostic test, no
longer the prevalence is incorporated into sample size calculation
for sensitivity/speciﬁcity [22]. For the purpose of testing, instead
of third element, the difference of sensitivity (or speciﬁcity) under
the null and alternative hypothesis is required (i.e. the maximum
difference to be detected in statistical test with power of 1  b
where b is the probability of type II error). Thus, the power of sta-
tistical test (the compliment of type II error) should be considered
the prior sample size calculation. As a general rule, with higher
precision (i.e. the lower marginal error: the half wide of conﬁdence
interval) in estimating accuracy and detecting a small difference of
effect in testing of accuracy with higher power, a greater sample
size is required.6. Sample size for studies with binary test outcome
6.1. Sample size for adequate sensitivity/speciﬁcity
First, assume we wish to determine the number of cases to esti-
mate sensitivity (Se) of new diagnostic test. Similarly, one may
estimate speciﬁcity (Sp). Since sensitivity (or speciﬁcity) is a pro-
portion, for estimation of sensitivity (or speciﬁcity) alone when
the diseased status is known, the formula for sampler size with
(1  a)% conﬁdence level and with maximum marginal error of
estimate of d for constructing conﬁdence interval of true value of
sensitivity (or speciﬁcity) using normal approximation is driven
as follows:
n ¼
Z2a
2
bPð1 bPÞ
d2
ð6:1Þ
where bP is pre-determined value of sensitivity (or speciﬁcity) that is
ascertained by previous published data or clinician experience/
judgment and for a = 0.05, Za
2
is inserted by 1.96. This is an estimate
of sample size for sensitivity or speciﬁcity alone when the true con-
dition of disease status is known. Buderer [21] incorporated the
prevalence of disease in formula for sample sizes calculation when
the true disease status is not known at the time of sampling. This
might occur in prospective study when consecutive subjects under-
going the test are used as samples [22]. In practice, the clinicians
would like to estimate the number required both in sensitivity
and speciﬁcity within a study population containing cases and con-
trols. In this situation, to ensure the study sample which the test
will be applied is a representative of study population, the
proportion of cases and controls should be taken into account by
the prevalence of the disease in population.
Lets ncases, ntotal (cases and control) and Prev denote the number
of cases, the total sample sizes (cases and control) and theprevalence of disease respectively, then based on sensitivity, the
overall sample size (both cases and controls) is
ntotal ¼ ncasesPrev ð6:2Þ
In fact, if one divides the right hand side of Eq. (6.1) by the prev-
alence of disease in target population, it gives the total number of
subjects (cases and controls) need for sensitivity. The required
sample size of speciﬁcity is estimated by dividing the right hand
side of Eq. (6.1) by (1-prevalence) that gives the total subject for
speciﬁcity. Then, if one is interested for both sensitivity and spec-
iﬁcity, the largest value of two calculated total sample sizes will be
considered as total study samples.
If one knows the ntotal and ncases, one can simply calculate the
number of control that is needed to estimate speciﬁcity of new
diagnostic test as follows:
ncontrols ¼ ntotal  ncases ¼ ntotalð1 PrevÞ ð6:3Þ
Thus, based on speciﬁcity
ntotal ¼ ncontrols1 Prev ð6:4Þ
Simply one can drive the proportion of cases to controls as
follows
ncases
ncontrols
¼ Prev
1 Prev ð6:5Þ
Thus, the total sample sizes based on sensitivity and speciﬁcity
respectively are
nSe ¼
Z2a
2
cSeð1cSeÞ
d2  Prev
ð6:6Þ
nSp ¼
Z2a
2
cSpð1 cSpÞ
d2  ð1 PrevÞ
ð6:7Þ
For a = 0.05, Za
2
is inserted by 1.96; cSe;cSp, and Prev are the
pre-determined values of sensitivity, speciﬁcity and prevalence of
disease respectively and d as the precision of estimate (i.e. the
maximum marginal error) is pre-determined by clinical judgment
of investigators.
For example, if the Se is primary interested in diagnostic
screening purpose and lets the pre-determined values of Se and
prevalence of disease as 80% and 10% respectively. In order the
maximum marginal error of estimate does not exceed from 7%
with 95% conﬁdence level, the total required sample size can be
driven by plugging the above values in Eq. (6.6) as follows:
nSe ¼ 1:96
2  0:8 0:20
0:072  0:10 ¼ 1254
In Section 8 (Tables 1 and 2), we calculated and tabulated the
required total sample sizes with various values of Se, Sp, Prev
and marginal errors.
Obviously, the formula based on sensitivity and speciﬁcity yield
a similar sample size at prevalence of 0.5. With low prevalence, the
required sample size based on sensitivity is much higher than that
of speciﬁcity while the prevalence of diseased becomes more than
0.50 which is less intuitive appealing, the sample size based on
sensitivity lower than that of speciﬁcity. In practice, clinicians
may be guided ﬁrst to calculate the number of cases based on sen-
sitivity and then uses Eq. (6.5) to estimate the number of controls
but our thought intuitively hints that ﬁrst the maximum total
number of subjects based on sensitivity and speciﬁcity should be
taken into account and then the number of cases (or controls) be
calculated based on Eq. (6.5).
Table 1
The required total samples sizes for estimating sensitivity with respect to marginal error, sensitivity and the prevalence of disease in target population.
Sensitivity Marginal
error
0.01 0.05 0.10 0.15 0.20 0.25 0.30 0.40 0.50 0.01 0.05 0.1 0.15 0.2 0.25 0.3 0.4 0.5
n n n n n n n n n
Prevalence
0.70 0.03 89,637 17,927 8964 5976 4482 3585 2988 2241 1793 905 944 996 1055 1120 1195 1281 1494 1793
0.75 0.03 80,033 16,007 8003 5336 4002 3201 2668 2001 1601 808 842 889 942 1000 1067 1143 1334 1601
0.80 0.03 68,295 13,659 6830 4553 3415 2732 2277 1707 1366 690 719 759 803 854 911 976 1138 1366
0.85 0.03 54,423 10,885 5442 3628 2721 2177 1814 1361 1088 550 573 605 640 680 726 777 907 1088
0.90 0.03 38,416 7683 3842 2561 1921 1537 1281 960 768 388 404 427 452 480 512 549 640 768
0.95 0.03 20,275 4055 2028 1352 1014 811 676 507 406 205 213 225 239 253 270 290 338 406
0.70 0.05 32,269 6454 3227 2151 1613 1291 1076 807 645 326 340 359 380 403 430 461 538 645
0.75 0.05 28,812 5762 2881 1921 1441 1152 960 720 576 291 303 320 339 360 384 412 480 576
0.80 0.05 24,586 4917 2459 1639 1229 983 820 615 492 248 259 273 289 307 328 351 410 492
0.85 0.05 19,592 3918 1959 1306 980 784 653 490 392 198 206 218 230 245 261 280 327 392
0.90 0.05 13,830 2766 1383 922 691 553 461 346 277 140 146 154 163 173 184 198 230 277
0.95 0.05 7299 1460 730 487 365 292 243 182 146 74 77 81 86 91 97 104 122 146
0.70 0.07 16,464 3293 1646 1098 823 659 549 412 329 166 173 183 194 206 220 235 274 329
0.75 0.07 14,700 2940 1470 980 735 588 490 368 294 148 155 163 173 184 196 210 245 294
0.80 0.07 12,544 2509 1254 836 627 502 418 314 251 127 132 139 148 157 167 179 209 251
0.85 0.07 9996 1999 1000 666 500 400 333 250 200 101 105 111 118 125 133 143 167 200
0.90 0.07 7056 1411 706 470 353 282 235 176 141 71 74 78 83 88 94 101 118 141
0.95 0.07 3724 745 372 248 186 149 124 93 74 38 39 41 44 47 50 53 62 74
0.70 0.10 8067 1613 807 538 403 323 269 202 161 81 85 90 95 101 108 115 134 161
0.75 0.10 7203 1441 720 480 360 288 240 180 144 73 76 80 85 90 96 103 120 144
0.80 0.10 6147 1229 615 410 307 246 205 154 123 62 65 68 72 77 82 88 102 123
0.85 0.10 4898 980 490 327 245 196 163 122 98 49 52 54 58 61 65 70 82 98
0.90 0.10 3457 691 346 230 173 138 115 86 69 35 36 38 41 43 46 49 58 69
0.95 0.10 1825 365 182 122 91 73 61 46 36 18 19 20 21 23 24 26 30 36
Table 2
The required total sample sizes for estimating speciﬁcity with respect to marginal error, speciﬁcity and the prevalence of disease in target population.
Speciﬁcity Marginal error 0.01 0.05 0.10 0.15 0.20 0.25 0.30 0.40 0.5
n n n n n n n n
Prevalence
0.70 0.03 905 944 996 1055 1120 1195 1281 1494 1793
0.75 0.03 808 842 889 942 1000 1067 1143 1334 1601
0.80 0.03 690 719 759 803 854 911 976 1138 1366
0.85 0.03 550 573 605 640 680 726 777 907 1088
0.90 0.03 388 404 427 452 480 512 549 640 768
0.95 0.03 205 213 225 239 253 270 290 338 406
0.70 0.05 326 340 359 380 403 430 461 538 645
0.75 0.05 291 303 320 339 360 384 412 480 576
0.80 0.05 248 259 273 289 307 328 351 410 492
0.85 0.05 198 206 218 230 245 261 280 327 392
0.90 0.05 140 146 154 163 173 184 198 230 277
0.95 0.05 74 77 81 86 91 97 104 122 146
0.70 0.07 166 173 183 194 206 220 235 274 329
0.75 0.07 148 155 163 173 184 196 210 245 294
0.80 0.07 127 132 139 148 157 167 179 209 251
0.85 0.07 101 105 111 118 125 133 143 167 200
0.90 0.07 71 74 78 83 88 94 101 118 141
0.95 0.07 38 39 41 44 47 50 53 62 74
0.70 0.10 81 85 90 95 101 108 115 134 161
0.75 0.10 73 76 80 85 90 96 103 120 144
0.80 0.10 62 65 68 72 77 82 88 102 123
0.85 0.10 49 52 54 58 61 65 70 82 98
0.90 0.10 35 36 38 41 43 46 49 58 69
0.95 0.10 18 19 20 21 23 24 26 30 36
196 K. Hajian-Tilaki / Journal of Biomedical Informatics 48 (2014) 193–204Alternatively, Li and Fine developed sample size for sensitivity
and speciﬁcity in prospective studies when disease status may
not be known at the time of enrolment since the gold standard
applied at pre-determined time after initial screening. They
developed a formal method of sample size calculation based on
unconditional power property of statistical test [26].
6.2. Sample size for testing sensitivity (or speciﬁcity) of single
diagnostic test
Suppose P0 denote the pre-determined value of sensitivity or
speciﬁcity of new diagnostic test. In comparing the test’s accuracy
to ﬁxed value of P0, the null and alternative hypothesis isH0 : Se ¼ P0 versus H1 : Se– P0 ðor Se ¼ P1Þ
where P1 is the value of sensitivity (or speciﬁcity) under alternative
hypothesis. A general sample size formula for comparison of
proportion with ﬁxed value can be applied for evaluation of single
diagnostic test. With (1  a)% conﬁdence level and (1  b)% power
for detection an effect of P1  P0 using normal approximation as a
general rule, Z-score under the null and alternative hypothesis
can deﬁned and thus the required sample size for cases is driven
as follows:
n ¼
Za
2
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
P0ð1 P0Þ
p þ Zb ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃP1ð1 P1Þph i2
ðP1  P0Þ2
ð6:8Þ
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2
and Zb denote the upper a2 and b percentiles of standard
normal distribution and a, b are the probability of type I and type
II errors respectively. For a = 0.05 and b = 0.20, they are inserted
by Za
2
¼ 1:96 and Zb = 0.84 respectively. In this paper, we used con-
sistently two side tests instead of one side test in our sample size
calculation; for one side test Za and Zb should be used.
For example, an investigator compares H0: Se = 0.70 versus H1:
Se– 0.70. The sample size one would need to have 95% conﬁdence
and 80% power to detect a difference of 10% from presumption va-
lue of Se = 70%, can be calculated by plugging in the above informa-
tion in Eq. (6.8) as follows:
n ¼ ð1:96
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
0:70 0:30
p
þ 0:84
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
0:80 0:20
p
Þ2
ð0:10Þ2
¼ 153
In Eq. (6.8), one may argue that why the prevalence was not ap-
peared in the formula. As we already mentioned since the true sta-
tus of disease is know in comparative situations. Therefore, the
prevalence is not relevant for sample size calculation in this
condition.6.3. Sample size for comparing the sensitivity (or speciﬁcity) of two
diagnostic tests
A general formula of sample size calculation for comparing two
independent proportions can be used to estimate sample size for
studies comparing sensitivity and/or speciﬁcity of two tests of un-
paired design. In comparing the diagnostic accuracy of two alterna-
tive tasks for two independent samples, suppose P1 and P2 denote
the expected proportion (Se or Sp) of two alternative diagnostic
tests respectively. For testing hypothesis: H0: P1 = P2 versus H1:
P1– P2, the required sample size with equal size based on normal
approximation of binomial data with 1  a conﬁdence level and
1  b power is
n ¼
Za
2
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2 Pð1 PÞ
q
þ Zb
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
P1ð1 P1Þ þ P2ð1 P2Þ
p 2
ðP1  P2Þ2
ð6:9Þ
where P the average of P1 and P2 and Za, Zb is are the standard nor-
mal Z values corresponding to a and b (the probability of type I and
type II errors respectively).
Suppose, one wishes to compare the Se of two alternative diag-
nostic tasks H0: P1 = P2 versus H1: P1– P2. The sample size would
one need to have 95% conﬁdence and 80% power to detect a differ-
ence of 10% from a Se of 70% (i.e. P1 = 0.70, P2 = 80% and P ¼ 0:75)
can be calculated by inserting this information in Eq. (6.9) as
follows:
n¼ ð1:96
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
20:750:25
p
þ0:84 ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ0:700:30þ0:800:20p Þ2
ð0:10Þ2
¼ 293
Epi info software can be used to perform these calculations and
to estimate the required sample size for proportion. Also the
approach can be extended for paired designs when multiple tests
are performed on the same subjects, then the proportion (Se or
Sp) should be considered as dependent. Beam [29] presented
formulae for calculation of sample size for paired designs; he has
also written a program in FORTRAN for calculation of sample sizes.
To avoid the increased complexity of this text for clinician, we
referred the interesting readers to previously published papers
[29–32].6.4. Sample size for likelihood ratio estimation
As we described when test yields positive or negative results,
sensitivity and speciﬁcity are the two inherent indexes of accuracy.
One may estimate sample size based on one of these two indexes
regarding preference of researcher either uses sensitivity or speci-
ﬁcity as primary of interest but LR that combines the sensitivity
and speciﬁcity of test as uni-dimensional index, is a greater of
interest. A test with higher LR+ has a greater value of rule in the
disease while a test with lower value of LR has a higher value of
rule out disease. These two indexes are particularly interesting in
comparative studies of two or multiple tests. The test with greater
value of LR+ and lower values of LR has more diagnostic abilities
in the classiﬁcation of true status of diseased and nondiseased.
Thus, positive LR and negative LR play an important rule for clinical
decision and they can be used in estimating sample size in diag-
nostic test. Simel et al. [24] proposed the conﬁdence interval of po-
sitive LR (or negative LR) to be used for sample size estimation. For
example, a clinical investigator wishes to calculate sample size
where the LR+ is greater from a pre-determined value of LR with
(1  a)% conﬁdence interval (i.e. a pre-determined value lies with-
in the conﬁdence bound with (1  a)% conﬁdence level.
Suppose bP1 and bP2 denote the sensitivity and 1-speciﬁcity of a
test respectively and n1 and n2 denote the sample size for diseased
and nondiseased. The ratio estimator of LRþ ¼ bP1bP2 is skewed and
the logarithm transformation can be used to convert its distribu-
tion to normal approximately. Thus, log
bP1bP2 can be assumed that
asymptotically normally distributed with standard error ofﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1bP1
n1bP1 þ 1bP2n2bP2
r
and therefore (1  a)% conﬁdence interval for log(LR+)
is as follows:
logðLRþÞ ¼ log
bP1bP2  Za2
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1 bP1
n1bP1 þ 1
bP2
n2bP2
s
ð6:10Þ
With the presumption of equal sample size for diseased and
nondiseased (i.e. n1 = n2 = n), then the required sample size for
each group of cases and controls can be calculated by solving the
Eq. (6.10) as follows:
n ¼
Za
2
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1bP1bP1 þ 1bP2bP2
r 2
logðLRþÞ  logbP1bP2
 2 ð6:11Þ
For example, an investigator wishes to estimate the sample size of a
study where LR+ has more valuable when LR+P 2. Given the result
of pilot study, sensitivity = 0.8 and speciﬁcity = 0.7 and thus
LRþ ¼ Se1Sp ¼ 2:96. For sample size calculation, we substituted
LR = 2 for lower bond of conﬁdence interval. With the presumption
of equal sample size for diseased and nondiseased (i.e. n1 = n2 = n),
then the required sample size can be calculated by solving the fol-
lowing equation:
2 ¼ exp log 0:8
0:7
 1:96
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
n
 
0:2
0:8
þ 0:7
0:3
  s
ð6:12Þ
n = 74 for each group and thus, the total sample size would be 148.
With these sample sizes the investigator 95% of time to be conﬁdent
that positive LR is greater than 2 (i.e. the LR of 2 lies below the lower
bound of 95% conﬁdence interval). One also can assume the ratio of r
for controls (n1) to cases (n2), then n2 = r  n1. By replacing r  n1 in-
stead of n2, the solution of Eq. (6.10) yields sample size for cases (n1).
In another condition, a diagnostic test may be useful, if negative
LR is lower than a pre-determined value. Then, the sample size
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Similarly, one could drive a conﬁdence interval for LR as follows:
logðLRÞ ¼ log
bP1bP2  Za2
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1 bP1
n1bP1 þ 1
bP2
n2bP2
s0@ 1A ð6:13Þ
where bP1 ¼ Sp and bP2 ¼ 1 Se.
For example, from a clinical point of view, a test is useful when
the maximum value of negative LR about 0.4 and from literature
review Se = 0.9 and Sp = 0.5. With presumption of n1 = n2 = n, the
required sample size is calculated by solving the following equa-
tion with respect to n,
log 0:4 ¼ log 0:9
0:5
þ 1:96
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
n
 
0:9
0:1
þ 05
0:5
 s
ð6:14Þ
Thus, n = 80 for each group and total sample size is 160.7. Sample size for studies of ROC index of accuracy
7.1. Sample size for estimating accuracy index
So far, we discussed sample size calculations when the test
yields a binary outcome. As we addressed already, for a quantita-
tive test or the test results are recorded on ordinal scale, ROC
curves show the trade off between sensitivity and speciﬁcity and
the area under the curve (AUC) is considered as an index of accu-
racy. The AUC can be estimated parametric (binormal model) and
nonparametric (Wilcoxon statistic) approaches. Both approaches
allow estimating the sampling variability of AUC. In diagnostic
studies, involving ROC analysis, for the purpose of estimating or
testing AUC, the clinicians should decide the number of patients
and controls needed in study protocol. Suppose a clinical research-
er wishes to estimate the diagnostic accuracy as deﬁned by AUC in
which the marginal error of estimate (i.e. the difference between
true AUC and its estimate) does not exceed from a pre-determined
value of d with (1  a)% conﬁdence level (e.g. 95%). Using normal
approximation in constructing conﬁdence interval for AUC, we
have
Za
2
SEðdAUCÞ 6 d ð7:1Þ
By squaring two sides of equation, then
Z2a
2
VarðdAUCÞ ¼ d2 ð7:2Þ
Lets VðdAUCÞ ¼ nVarððdAUCÞ. Thus, the required sample size for each
group of nondiseased and diseased is
n ¼
Z2a
2
VðdAUCÞ
d2
ð7:3Þ
The variance of dAUC denoted as Var(dAUC) can be estimated can be
estimated parametrically based on binormal assumption [22,33,34]
(see Appendix B) or exponential approximation using Hanley and
McNeil formula [15] (see Appendix A).
In numerical results that we produced the required sample size
in Section 9, we used binormal based variance of AUC as described
in Appendix B and we assumed n1 = n2 = n. Thus, the V(AUC) can
easily be driven from Eq. (A3) (see Appendix B) as follows:
nVarðdAUCÞ ¼ VðAUCÞ ¼ ð0:0099 ea2=2Þ  ð6a2 þ 16Þ ð7:4Þ
where a = u1(AUC)  1.414 and u1 is the inverse of standard
cumulative normal distribution.
For example, Suppose, the pre-determined value of AUC = 0.70,
in order to estimate AUC with 95% conﬁdence the degree ofprecision of estimate about 0.07, the required sample size can be
calculated as follows:
For estimating V(AUC), ﬁrst one should calculate a = u1(0.70) 
1.414 = 0.741502 and then, V(AUC) can be calculated using Eq. (7.4)
as:
VðAUCÞ ¼ ð0:0099 e0:7415022=2Þ  ð6 0:7415022 þ 16Þ
¼ 0:145136
Therefore, the required sample size is obtained by inserting the
V(AUC) and d = 0.07 in Eq. (7.3) as follows:
n ¼ 1:96
2  0:145136
0:072
¼ 114
Alternatively, the pure nonparametric method was proposed by
Delong et al. [35–37] (see Appendix C). This method is based on
structure components of individual based data which we called
as pseudo accuracies for both diseased and nondiseased subjects.
Hanley and McNeil formula [15] is a convenient method for
estimation of SE of AUC that only depends on estimate of accuracy
index (AUC) but it does not consider the ratio of standard deviation
of nondiseased to diseased populations. While the normal based
standard error is more ﬂexible to consider the ratio of two standard
deviations [33]. Both formulae take into account the ratio of con-
trols to cases. Obuchowski [33] reported that Hanley and McNeil
method underestimate the SE of AUC for rating data but not for
continuously distributed data while the normal based standard
error is more ﬂexible to consider the ratio of two standard errors
produces a conservative estimate of SE In a Monte Carlo simulation
studies with continuously distributed data, Hajian-Tilaki and
Hanley [38] showed that overall the three methods of SE of AUC
(binormal model, exponential approximation and Delong’s
method) worked well in reﬂecting actual variation for various
conﬁgurations of nonbinormal data while for bimodal data, the
binormal estimator of SE produces as more conservative estimate
of SE than others.
7.2. Sample size for testing accuracy of quantitative diagnostic test of
single modality
Assume a clinical researcher may wish to test the accuracy (AUC
as unknown parameter of interest) of a new diagnostic method
with a pre-speciﬁed value of AUC0. The null and alternative
hypothesis is
H0 : AUC ¼ AUC0 versus H1 : AUC– AUC0 ði:e: AUC ¼ AUC1Þ
Using the normal approximation, the required sample size for
each group of cases and controls (assuming the ratio of cases to
controls is one) in detecting an effect of d = AUC1  AUC0 with
(1  a)% conﬁdence level and (1  b)% power is as follows
n ¼
Za
2
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
VH0ð dAUCÞq þ Zb ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃVH1ð dAUCÞq 2
½AUC1  AUC02
ð7:5Þ
where VðdAUC ¼ nVarðdAUCÞ. VarH0ðdAUCÞ and VarH1ððdAUCÞ denote
the variance of dAUC under the null and alternative hypothesis
respectively.
7.3. Sample size for comparing accuracy of two diagnostic tests
In comparative study of two diagnostic tasks in the context of
ROC analysis, for example, a clinical investigator has a plan to com-
pare the accuracy of MRI and CT in detecting abnormal condition.
The accuracy of these two diagnostic tasks is determined by AUC
and the same subjects are undergoing two alternative tasks for
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conditions. Let AUC1 and AUC2 are the true two diagnostic accura-
cies for the two diagnostic modalities respectively. The null and
alternative hypothesis are
H0 : AUC1 ¼ AUC2 versus H1 : AUC1 – AUC2
The investigator wants to decide how many cases and controls
are needed to detect an effect between two diagnostic tasks as
deﬁned by d = AUC1  AUC2 under alternative hypothesis with
(1  a)% conﬁdence level and (1  b)% power. By constructing
conﬁdence interval for parameter of interest AUC1  AUC2 using
normal approximation under the null and alternative hypothesis,
then the required sample sizes for each group are driven as
n ¼
Za
2
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
VH0ðdAUC1  dAUC2Þq þ Zb ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃVH1ðdAUC1  dAUC2Þq 2
½AUC1  AUC22
ð7:6Þ
where
VðdAUC1  dAUC2Þ ¼ nVarðdAUC1Þ þ nVarðdAUC2Þ
 2nCovðdAUC1; dAUC2Þ ð7:7Þ
In Eq. (7.6), the VarðdAUC1  dAUC2Þ needs to be estimated under the
null (H0) and alternative hypothesis (H1). In a case, two diagnostic
tasks do not apply on the same subjects, then the two AUC’s are
independent and the Eq. (7.6) can be written as:
n ¼
Za
2
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2VH0ðdAUCÞq þ Zb ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃVðdAUC1Þ þ VðdAUC2Þq 2
½AUC1  AUC22
ð7:8Þ
where the AUC under the H0 is the average of AUC1 and AUC2.
For example for detection of 10% difference in estimating two
independent diagnostic systems with 95% conﬁdence and 80%
power, assuming AUC1 = 0.70 and AUC2-AUC1 = 0.10 using binor-
mal based variance of AUC as described in Section 7.1, on could
easily calculate V(AUC)H0 = 0.13480; V(AUC1) = 0.14513; V(AUC2) -
= 0.11946. Then the required sample size for each task with 80%
power and 95% conﬁdence for detection 10% difference in accuracy
index (AUC) using Eq. (7.8) as
n ¼ ½1:96
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2 0:1348
p
þ 0:84 ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ0:14513þ 0:11946p 2
ð0:10Þ2
¼ 211
In the following Section 9, we also calculated the required
sample sizes in different situation of AUC and effect size and it is
tabulated in Table 7 for two independent AUC.
The VarðdAUC1Þ and VarðdAUC2Þ can also be estimated using
Hanley and McNeil formula [15] but it does not gives the
covariance between two correlated AUC’s. While the advantage
of Delong’s method [35,36] is that the covariance between two cor-
related AUC’s can be estimated from its components of variance
and covariance matrix as well. In addition, CORROC software (Metz
Software) also estimates the covariance between the two corre-
lated AUC’s in parametric approach of comparative study of two
diagnostic tasks [39].
CovðdAUC1; dAUC2Þ ¼ rSEðdAUC1Þ  SEðdAUC2Þ ð7:9Þ
where and SE denote the correlation between the two estimated
AUC’s and the standard error (i.e. the square root of variance) of
estimate of AUC’s respectively. If the two diagnostic tasks are not
examined on the same subjects, the two estimated AUC to be inde-
pendent and thus the covariance term will be zero. The investigator
may assume the ratio of sample size for the controls to the cases to
be as R. Then, the sample size can be estimated for each group with
this ratio.Although AUC as an overall accuracy index is admired as robust
index with meaningful interpretation and primarily interesting in
diagnostic accuracy, in comparing of AUC from two diagnostic
tasks when two ROC curves crossing each other, this overall index
may be not useful. The partial area at clinical relevant of false po-
sitive and true positive fraction at speciﬁc false positive rate
(TPFFPF) are the two other indexes of accuracy that had been con-
sidered in ROC analysis. The methods have been developed for
sample size calculations of partial area and TPFFPF [22]. In addition,
ROC studies in particular for rating data may be involved with mul-
tiple readers. Obuchowski provided tables of calculated sample
size for multiple reader studies. The interesting readers are re-
ferred to some published articles in this area [22,40].8. Sample size calculation
We calculated sample size using Excel software (Windows of-
ﬁce 2007) for purpose of estimating of different diagnostic accura-
cies (sensitivity, speciﬁcity, LR and AUC) and of testing as well,
assuming the ratio of sample sizes for cases and controls to be
one. We provided tables of required samples for combinations of
various conditions. In particular, for estimating and testing of
AUC in single modality and comparative study of two correlated
and independent accuracy index (AUC), we used binomial based
variance with standard ratio of one. For the two correlated AUC
when the two alternative tasks are applied on the same subject,
we assumed the correlation of 0.5. A correlation between two
accuracies close to this value was reported by Rockette et al.
[41]. Obviously, if the different samples of patients underwent
the two different diagnostic tasks, then the correlation would be
zero. We examined the required sample sizes with a wide range
of accuracy indexes from 0.60 to 0.98 and a rational range of mar-
ginal errors and different effects (varied from 0.03 to 0.15) with
95% conﬁdence level and 80% power.9. Results of sample size calculation
Table 1 shows that the required total sample size for sensitivity
is substantially varied in relation to marginal errors (i.e. the differ-
ence between the estimates and true value that is expected to be
detected or one half the desired width of the conﬁdence interval),
the degree of sensitivity and the prevalence of disease in popula-
tion. The greatest sample size of 89,637 was calculated for low
marginal errors (0.03) and low sensitivity (0.70) and low preva-
lence (0.01). For a given sensitivity and a marginal error, the sam-
ple size substantially decreased as prevalence reached to 0.50. The
smallest sample size for sensitivity was calculated when the prev-
alence was about 0.50. For example, for the sensitivity of 0.70 and
the marginal error of 0.03, the required sample size basically varied
from 89,637 to 179 as prevalence elevated from 0.01 to 0.50. In
addition, for a given prevalence and marginal error, sample size de-
creased as sensitivity increased. Table 2 shows that the required
total sample size for speciﬁcity increases by higher prevalence of
disease. The largest sample size was calculated for low speciﬁcity
and low marginal errors and high prevalence (the ﬁrst row of Table
2). The smallest one was computed for high accuracy, high mar-
ginal error and low prevalence. In Table 3, the third column shows
the point estimate of LR+, as conﬁdence bound of LR+ becomes
wider which included with higher marginal error, the sample size
decreased since LR as ratio estimator is more sensitive with respect
to variation of sensitivity and speciﬁcity. A wider conﬁdence bound
of LR+ (the difference between the third column and the boundary
value) (i.e. lower precision) which is unacceptable statistically and
clinically as well, produces a small sample size. Similarly, Table 4
shows the narrower of conﬁdence bound for LR (i.e. the lower
Table 3
Calculation of sample sizes for estimation of LR+ within a 95% conﬁdence level.
Sensitivity Speciﬁcity Estimated LR+ LR+ = 2 LR+ = 2.5 LR+ = 3 LR+ = 3.5 LR+ = 4 LR+ = 4.5 LR+ = 5 LR+ = 6
0.70 0.60 1.75 416 58 26 15 11 8 7 5 2 3 2 2
0.75 0.60 1.88 1691 85 32 18 12 9 7 5 2 3 2 3
0.80 0.60 2.00 – 135 41 21 14 10 8 6 2 3 2 3
0.85 0.60 2.13 1752 244 54 26 16 11 9 6 2 4 2 3
0.90 0.60 2.25 446 558 75 32 19 13 10 6 2 4 2 3
0.95 0.60 2.38 202 2267 109 40 22 15 11 7 2 4 2 3
0.70 0.70 2.33 447 2229 168 65 37 25 18 12 3 7 2 5
0.75 0.70 2.50 206 – 308 90 46 30 21 13 3 8 2 5
0.80 0.70 2.67 120 2383 715 134 60 36 25 15 3 8 2 6
0.85 0.70 2.83 79 615 2951 216 81 45 30 17 3 9 2 6
0.90 0.70 3.00 57 282 – 395 113 57 36 20 3 10 3 6
0.95 0.70 3.17 43 164 3136 915 168 74 44 22 3 11 3 7
0.70 0.80 3.50 54 150 716 – 954 269 134 59 5 25 4 15
0.75 0.80 3.75 42 101 334 3497 3997 501 201 75 5 29 4 17
0.80 0.80 4.00 34 74 197 916 – 1177 328 99 6 34 4 19
0.85 0.80 4.25 28 57 132 426 4365 4911 607 135 6 40 5 22
0.90 0.80 4.50 24 46 96 250 1138 – 1423 191 7 48 5 25
0.95 0.80 4.75 21 38 74 167 527 5326 5917 285 8 57 5 28
0.70 0.90 7.00 23 34 50 75 116 186 320 1524 45 2031 17 285
0.75 0.90 7.50 21 30 43 62 91 137 218 720 93 8608 21 433
0.80 0.90 8.00 18 26 37 52 74 107 161 429 27 714
0.85 0.90 8.50 17 24 33 45 62 87 125 291 98 9592 37 1335
0.90 0.90 9.00 15 21 29 39 53 73 101 213 50 2523 56 3153
0.95 0.90 9.50 14 20 26 35 46 62 84 165 34 1178 115 13,218
0.70 0.95 14.00 20 25 31 39 48 58 70 104 15 238 26 659
0.75 0.95 15.00 18 23 29 35 43 51 62 88 14 188 21 452
0.80 0.95 16.00 17 21 26 32 38 46 55 77 12 154 18 335
0.85 0.95 17.00 16 20 24 29 35 42 49 68 11 130 16 262
0.90 0.95 18.00 15 19 23 27 32 38 45 61 11 112 15 212
0.95 0.95 19.00 14 18 21 26 30 35 41 55 10 98 13 178
Table 4
Calculation of sample sizes for estimation of LR within 95% conﬁdence level for pre-determined value of LR.
Sensitivity Speciﬁcity Estimated LR LR = 0.05 LR = 0.10 LR = 0.15 LR = 0.20 LR = 0.30 LR = 0.40 LR = 0.50 LR = 0.60
0.70 0.60 0.50 2 4 8 14 44 231 – 347
0.75 0.60 0.42 3 7 13 26 131 8453 424 106
0.80 0.60 0.33 5 12 28 69 1615 539 109 52
0.85 0.60 0.25 9 29 93 489 732 110 51 32
0.90 0.60 0.17 26 142 3345 1117 107 48 31 23
0.95 0.60 0.08 290 2273 219 99 46 31 24 19
0.70 0.70 0.43 2 5 10 18 83 2229 447 94
0.75 0.70 0.36 3 8 18 39 433 1026 116 49
0.80 0.70 0.29 6 15 41 134 7147 150 54 31
0.85 0.70 0.21 11 40 184 4919 207 60 33 22
0.90 0.70 0.14 33 285 15,216 320 66 34 23 18
0.95 0.70 0.07 587 659 136 70 36 25 20 16
0.70 0.80 0.38 2 6 12 25 199 2383 120 45
0.75 0.80 0.31 4 10 23 63 7492 205 57 29
0.80 0.80 0.25 6 19 63 328 491 74 34 21
0.85 0.80 0.19 13 58 456 5457 103 40 24 17
0.90 0.80 0.13 42 714 1069 161 46 26 18 14
0.95 0.80 0.06 1485 335 96 55 30 21 17 14
0.70 0.90 0.33 3 6 15 36 846 282 57 27
0.75 0.90 0.28 4 11 31 111 2018 90 35 20
0.80 0.90 0.22 7 25 102 1423 175 46 24 16
0.85 0.90 0.17 15 85 1999 668 64 29 18 14
0.90 0.90 0.11 55 3153 389 101 35 21 15 12
0.95 0.90 0.06 6614 212 74 45 26 19 15 13
0.70 0.95 0.32 3 7 17 44 3484 164 43 22
0.75 0.95 0.26 4 13 37 156 683 67 28 17
0.80 0.95 0.21 8 28 135 5917 124 38 21 14
0.85 0.95 0.16 17 105 8351 393 53 25 17 12
0.90 0.95 0.11 63 13,218 277 84 32 20 14 11
0.95 0.95 0.05 27,819 178 67 41 24 18 14 12
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with higher sample sizes.
Table 5 shows for estimation of AUC with a given marginal error
of 0.03 and 95% conﬁdence level, sample sizes varied from 665 to
42 for low (AUC = 0.60) to high (AUC = 0.98) accuracy index. Formoderate marginal error (0.05), the required sample size was
240 and 50 from low to high accuracy. Table 6 shows for testing
AUC with pre-determined ﬁxed value and for detecting an effect
of 0.03 with 95% conﬁdence level and 80% power, the sample sizes
varied from 1317 to 716 for low to high accuracy while for
Table 5
The calculated sample sizes for each group of diseased and nondiseased in estimating
diagnostic accuracy (AUC) in various conﬁgurations of AUC and marginal errors with
95% conﬁdence level.
AUC d = 0.03 Marginal d = 0.05 Errors d = 0.07 d = 0.10
n n n n
0.60 665 240 122 60
0.65 648 234 119 59
0.70 620 232 114 58
0.73 596 215 110 54
0.75 576 208 106 52
0.78 540 194 99 49
0.80 510 184 94 46
0.83 458 165 85 42
0.85 418 151 77 38
0.88 347 125 64 32
0.90 293 106 57 27
0.93 202 73 38 –
0.95 137 50 – –
0.98 42 – – –
Table 6
The required sample sizes for each group of diseased and nondiseased for testing the
accuracy of single diagnostic method (H0: AUC = AUC0 versus H1: AUC = AUC0 + d)
with different values of AUC and effect (d) with 95% conﬁdence level and 80% power.
AUC n n n n n n
d = 0.03 d = 0.05 d = 0.07 d = 0.10 d = 0.12 d = 0.15
0.60 1317 469 240 117 80 51
0.65 1293 464 234 113 78 49
0.70 1259 458 226 108 74 46
0.73 1233 455 220 105 71 43
0.75 1212 452 215 102 69 41
0.78 1175 448 206 96 64 38
0.80 1145 445 199 92 61 35
0.83 983 441 187 85 55 30
0.85 1053 438 177 78 49 24
0.88 979 433 158 66 –
0.90 920 429 143 54 – –
0.93 811 425 – – – –
0.95 716 – – – – –
Table 7
The required sample sizes for each group of diseased and nondiseased for comparison
of two diagnostic methods for two independent samples for detection an effect of
d = AUC1  AUC2 and for different AUCs and effects (d) with 95% conﬁdence level and
80% power.
AUC1 N n N n n n
d = 0.03 d = 0.05 d = 0.07 d = 0.10 d = 0.12 d = 0.15
0.60 2696 966 490 238 164 103
0.65 2615 933 472 227 156 97
0.70 2482 881 442 211 143 88
0.73 2369 837 418 197 133 81
0.75 2278 801 398 186 125 80
0.78 2111 736 362 167 110 65
0.80 1979 685 335 152 100 57
0.83 1744 595 286 126 80 44
0.85 1562 526 248 106 66 36
0.88 1248 407 185 74 44 –
0.90 1012 319 139 52 – –
0.93 626 202 70 – – –
0.95 361 90 – – – –
Table 8
The required sample sizes for each group of diseased and nondiseased for comparison
of two diagnostic methods on the same subjectsa for detection an effect of
d = AUC1  AUC2 and for different AUCs and effects (d) with 95% conﬁdence level
and 80% power.
AUC1 n n n n n n
d = 0.03 d = 0.05 d = 0.07 d = 0.10 d = 0.12 d = 0.15
0.60 2243 804 408 198 136 86
0.65 2176 777 393 189 130 81
0.70 2065 733 369 176 120 74
0.73 1972 697 348 165 111 68
0.75 1896 667 332 156 105 67
0.78 1758 614 303 140 93 56
0.80 1648 571 280 128 84 50
0.83 1453 497 240 107 69 41
0.85 1301 439 209 91 59 35
0.88 1041 342 158 66 44 –
0.90 846 270 121 52 – –
0.93 527 172 69 – – –
0.95 310 – – – – –
a The correlation between two AUCs was assumed as 0.50.
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240 for low and 143 for high AUC.
Tables 7 and 8 show that for the comparison of two indepen-
dent diagnostic tasks, as one expected the required sample size
was greater than that of the two correlated indexes in similar
conditions. For example the required sample size for each group
for detecting an effect of 0.07 with 95% conﬁdence and 80% power
in comparison of two independent AUC is equal to 490 for low
accuracy and 70 for high accuracy while for two correlated AUC
for detecting of the same effect and the same conﬁdence and
power, the required sample size decreased to 408 for low and to
69 for high accuracy (Table 8).10. Illustration of analysis and sample size with an example
As an example of biomedical informatics study illustrated in
Section 2, the performance of three diagnostic tasks (physician
alone, HDP alone and their combination) was assessed for predic-
tion of heart failure [12]. First the author used sensitivity and spec-
iﬁcity in their analysis. Then, they acknowledged the limitation of
sensitivity and speciﬁcity that depending on threshold used. Thus,
they performed ROC curve analysis. The ROC curves were depicted
for physician alone and HDP alone and also some points for their
combination. They only tested for comparison of sensitivity and
speciﬁcity but not for AUC. They just descriptively reported AUC
were 68.8%, 70% for physician alone and HDP alone respectively.They descriptively presented and concluded that the combination
of HDP and physician gave better discrimination than HDP pro-
gram and physician alone without reporting the p-values. It is
more helpful to report the AUC for the combination of two tasks
and the SE of each task and their conﬁdence interval of difference
of accuracy of two alternative tasks. Since this study used a
matched paired design, we recommend the SE of difference of
AUCs to be calculated using Delong’s method. However, it is not
clear with the small difference observed in ROC curves this differ-
ence would be signiﬁcant with the achieved sample size. In addi-
tion, they also reported the sensitivity of HDP alone was
signiﬁcantly higher than physician alone (0.53% versus 34.8%,
p < 0.001) while physician alone had higher speciﬁcity than HDP
alone (93.9% versus 75.6%) but their depicted ROC curves did not
shows such a differences in ROC space. Although, they reported
p-values for comparison of sensitivity and speciﬁcity of different
tasks, reporting the CI would have been more informative. Also
reporting SE of AUC or its CI and the p-value also would be
informative instead of a visualized comparison. Sample size con-
sideration was necessary and the power calculation would help
in particular the difference between two diagnostic classiﬁers
was not detected to be signiﬁcant with achieved sample size. The
calculated sample size in our Table 8 shows with paired design
for AUC about 70% and for detection of an effect of 10%, the
required sample size is 108 subjects for each group of cases and
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12%, this sample size is reduced to 71 for each group of cases
and control.11. Summary guideline
Listed below is recommendation for sample size calculation in
diagnostic studies with respect type of study and classiﬁer.
1. In a single diagnostic test with dichotomized outcomes, if an
investigator interested in sensitivity and speciﬁcity of perfor-
mance of diagnostic test, depending on conditions for estimat-
ing accuracy and desirable marginal error of estimates as
outlined in formula in Sections 6.1 and 6.2, the required sample
size can be chosen with respect to sensitivity (or speciﬁcity) and
prevalence of disease in Tables 1 and 2.
2. For comparison of sensitivity (or speciﬁcity) of two diagnostic
tests with dichotomized outcome for detection of a desirable
effect between two tasks with 95% CI, choose the formula in
Sections 6.2 and 6.3 for sample size calculation.
3. For a dichotomized classiﬁer when the choice of accuracy index
is the LR+ or LR, depending on condition which is more inter-
ested from clinical prospective, one can choose the sample size
in Tables 3 and 4 or using formula in Section 6.4.
4. When the diagnostic test results are recorded in ordinal or con-
tinuous scale, ROC curve analysis is the choice of interest and
AUC is primarily of interested accuracy index. In estimating
purpose, for a given AUC and desired marginal errors of the esti-
mates as outlined in Table 5, select the optimal sample size.
5. For testing AUC with a pre-speciﬁed value in a single diagnostic
task, depending on the AUC and the effect to be detected with
80% power and 95% CI, choose Table 6 for the required sample
size.
6. For comparison of two independent AUCs, given a base value for
AUC and desirable effect size with 80% power and 95% CI, select
Table 7 for minimum sample size of each group.
7. For comparison of two diagnostic tasks in paired design, choose
Delong method for estimation of SE of difference of AUCs of two
correlated tasks. Select the possible value of AUC and the desir-
able effect size with 80% power and 95% CI in Table 8 for the
optimal sample size of each group.
8. Additionally, in any of the above conditions, if the required
sample size is not achieved in practice, the calculation of power
of achieved sample size is needed if it differs from required
sample size.
12. Discussion
In this review, we have shown the various sample size estima-
tor methods for diagnostic studies. We provided the tables for the
required samples size with different conﬁgurations of accuracy in-
dexes and effect sizes/marginal errors. Our ﬁndings show that the
required sample size not only depend on the effect size/marginal
errors but also depend on the accuracy index for a given conﬁdence
level and power. Higher accuracy produces smaller sample size
since higher accuracy has less room for sampling variations (i.e.
less SE) in ROC space. A similar discussion is relevant regarding
the range of ROC curve. The ROC curve is progressively located in
the right corner of ROC space (AUC > 0.90), corresponding to lower
sampling variability, as our results shows the required sample size
for a given effect size and power is lower than ROC curve located
toward the diagonal line (AUC = 0.60). This happens because of
high sampling variability of AUC around diagonal line. Thus, it is
important that the investigators compute sample size using an
accuracy index that is relevant in clinical practice or from previouspublished data. Thus, the values of sensitivity/speciﬁcity, LR and
AUC that are expected in clinical settings, should be considered.
The various degrees of these parameters were presented in the
1st column of our tables of required sample sizes.
On the other hand, the sampling variability of accuracy index
may depends on the underlying distribution of data of diagnostic
test results and the model used to estimate ROC index and its SE.
If the underlying distribution of test results is close to binormal,
then the binormal SE of AUC is more reliable [37]. In a case of non-
binormal data, particularly bimodal data, the Delong method of
nonparametric estimate of SE of AUC represents the actual varia-
tion but binormal model produces a conservative estimate of SE
[38].
In relation of sample size with LR+ (or LR), the combination of
various boundary values of LR+ and point estimate that is derived
from observed sensitivity and speciﬁcity, as boundary value largely
differs from point estimate that corresponds with higher marginal
errors, the calculated sample size becomes very small (n < 30).
These sample sizes produce unreliable estimate of LR. Thus, we
do not recommend such a sample size in clinical practice. For
example, as presented in our results (Table 3) with observed value
of LR+ = 1.75, assuming the minimum value of LR+ = 6 produced a
small sample size of 5 for each group. The corresponding marginal
errors are relatively high (the wide of conﬁdence interval is
6–1.75 = 4.25 and thus the percentage size of marginal error is
about 4:251:75 ¼ 242:8% while for minimum boundary of 2.5 for LR+,
the percentage of error in wide of CI is about 0:751:75 ¼ 42:3% that pro-
duced a sample size of 416 for each group.
The major component of sample size estimator is involved with
sampling variability of accuracy under the null and alternative
hypothesis. Regarding to AUC, at least three methods (Hanley
and McNeil method [15], binormal estimator [22,33,24] and De-
long’s method [35,36] have been proposed for SE of AUC. Hanley
and McNeil formula which uses exponential approximation for
SE of nonparametric AUC (Wilcoxon statistic), has important role
in inferences on ROC analysis for simplicity of its calculation but
it only involves one parameter distribution (AUC). This method al-
lows to estimate SE in a single modality and also for difference of
two independent AUC. However, it does not provide the covariance
between two correlated AUC. Hanley and McNeil method of sam-
ple size estimator underestimates the actual variation for rating
data, particularly, when the standard deviation (SD) ratio differs
greatly from one [25] while the binormal estimator of SE is more
ﬂexible and it allows including a wide range of ratio of two stan-
dard deviations. It produces a conservative estimate of SE that is
preferable in sample size calculation [38]. With continuously
distributed data, Hajian-Tilaki and Hanley [38] showed that the
binormal estimator of SE of AUC reﬂects actual variation or it tends
slightly to be greater than empirical SE with binormal data while it
produces more conservative estimates of SE with nonbinormal
data, particularly for bimodal data. In panning ROC study, gener-
ally, the method produces a conservative estimates of SE is a great
of interest to determine sample size that will allow achieving a
higher statistical power. Thus, we used binormal estimator in our
sample size calculations and for simplicity the ratio of two SD
was considered to be close to one.
The required sample size presented in Tables 1–8 do not guar-
antee for subgroup analysis because of lack of power in statistical
test due to paucity of number of patients in each subgroup. The
investigator may decide such analysis for exploration of his ﬁnd-
ings but we emphasize any subgroup analysis must be decided at
the stage of design and sample size calculation in study protocol.
However, it was rarely taken into account at this stage in clinical
practices [19,20].
The methods of sample size calculation presented in this article,
are based on asymptotic theory of normal approximation. This
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close to one but this occurs rarely in diagnostic studies. The new
diagnostic test may usually have the accuracy at intermediate level
(0.70–0.90). However, the exact method of conﬁdence bound for
accuracy based on binomial distribution particularly for sensitivity
and speciﬁcity are recommended [42,43].
In comparative studies of two diagnostic tasks, obviously sam-
ple sizes are inﬂuenced by study design. In clinical practice, paired
design is more efﬁcient in term of precision of estimates (i.e. less SE
for difference of two estimates of AUC) for a given sample size and
power. In our sample size calculation for paired design when the
two tests are applied consecutively on the same subjects, we as-
sumed the correlation between two accuracy indexes to be close
to 0.50. Such a correlation has been reported in clinical practices
of diagnostic accuracy by Rocket et al. [41].
The half-width of a conﬁdence interval as one of the quantities
required in order to plan a sample size. While this is true for
quantities that have symmetrical conﬁdence intervals, this may
be rather inappropriate for proportions especially ones such as
sensitivity and speciﬁcity, for which we aim for high values. Thus,
the simple symmetrical Wald interval has some well recognized
limitations for use when actually calculating a CI for proportion,
to such a degree that caution is needed even for its use in planning
sample sizes. The better intervals are asymmetrical about the
empirical estimates that have been discussed by several authors
[44–46]. A similar issue applies to the intervals for the area under
the ROC curve.
The other aspects of study design affect on sample size, for
example, in some clinical settings, more than one unit of
observation per patient are taken (2 or more lesion per person in
evaluation of breast cancer screening by mammography) [40].
These units of observations from the same subjects are not inde-
pendent statistically and cannot be analyzed as independent
required sample size. Hajian-Tilaki et al. [47] developed methods
for multiple signal data per patient that is based on structure com-
ponents of Delong’s method that are called as pseudo accuracy for
each signal and each person. However, our tables of sample size
assume one unit per patient. This might be a new area of research
to develop statistical tools for sample size calculations whenmulti-
ple lesions are as a unit of observation per patient.
It is necessary to determine that the required sample size for
corresponding new statistical methods uses in diagnostic study
and more simulation study needs to assess the performance of
the different approaches of SE estimator of diagnostic accuracies
in sample size and power calculations in diagnostic studies.Appendix A
The variance of nonparametric AUC (Wilcoxon statistic) is
estimated using the methods that proposed by Bamber [48] as
VarðdAUCÞ ¼ AUCð1 AUCÞ þ ðn1  1ÞðQ1  AUC2Þ þ ðn2  1ÞðQ2  AUC2Þ
n1n2
ðA1Þ
Hanley and McNeil [7] used exponential approximation to
estimate Q1 and Q2 as
Q1 ¼
AUC
2 AUC and Q2 ¼
2AUC2
1þ AUC
that allows one to estimate the variance of AUC and its SE. Thus, the
variance of AUC under the null and also alternative hypothesis can
be estimated easily.
For studies with continuous test results VarðdAUCÞ can be
written approximatelyVarðdAUCÞ ¼ Q1
r
þ Q2  AUC2
1
r
þ 1
 
ðA2Þ
where r the ratio of sample size of controls to cases ðr ¼ n2n1Þ.
Appendix B
The two parameters of ROC curves based on binormal assump-
tion are deﬁned as a ¼ l2l1r1 and b ¼
r1
r2
where l1 and r1 the mean
and standard deviation of distribution for nondiseased and l2 and
r2 are for diseased distribution respectively. The area under curve
with binormal model is AUC ¼ u½ a
1þb2 where u is the cumulative
distribution function. Delta method can be used to estimate vari-
ance and SE of AUC. With an approximation when the ratio of SD
is close to one (i.e. b = 1) the binormal estimator of variance of
ðdAUCÞ is
VarðdAUCÞ ¼ ð0:0099 ea2=2Þ  5a2 þ 8
n2
þ a
2 þ 8
n1
 
ðA3Þ
where a = u1(AUC)  1.414 and n1 and n2 are the sample size for
nondiseased and diseased [22].
Appendix C
Let Xi, i = 1, 2, . . . ,n denote test results for a sample of n nondis-
eased subjects, and Yj, j = 1, 2, . . . ,m denote for m diseased sub-
jects. For each (Xi, Yj) pair, an indicator function I(Xi, Yj) is deﬁned
as follows:
IðXi;YjÞ ¼ 1 if Yj > Xi
1=2 if Yj ¼ Xi
0 if Yj < Xi
ðA4Þ
The average of these I’s over all n m comparisons is the Wilcoxon
or Mann Whitney U-statistic. The U is equivalent to the area under
the empirical ROC curve, and the expected value of U is the area un-
der the theoretical (population) ROC curve [15]. An alternative rep-
resentation, used by DeLong et al. [35] is to deﬁne the components
of the U-statistic for each of the n nondiseased subjects and for each
of m diseased subjects as
VNðXiÞ ¼ 1m
Xm
j¼1
IðXi;YjÞ ðA5Þ
VDðYjÞ ¼ 1n
Xn
i¼1
IðXi;YjÞ ðA6Þ
We will call the individual VN(Xi)’s and VD(Yj)’s ‘‘pseudo-values’’ or
‘‘pseudo-accuracies’’. The pseudo-value, VN(Xi), for the ith subject
in the nondiseased group, is deﬁned as the proportion of Y’s in
the sample of diseased subjects where Y is greater than Xi. Likewise
VD(Yj), for the jth subject in the diseased group is deﬁned as the pro-
portion of X’s in the sample of nondiseased subjects whose X is less
than Yj. The average of the n{VN}’s and the average of them{VD}’s are
both equivalent to the U-statistic.
Hanley and Hajian-Tilaki [36] restated the DeLong’s method of
calculating the variance of the accuracy index in a single diagnostic
test is as follows:
Var½U ¼ Var½VN 
n
þ Var½VD
m
ðA7Þ
The advantage of DeLong’s method is to compare the areas
under two or more ROC curves (1 curve per diagnostic system)
obtained from the same sample of subjects. In a setting with two
diagnostic systems, if we denote the estimates of accuracy indices
of two compared systems by A1 and A2, then the SE(A1  A2) is
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V2 = {V2N, V2D} and the sample sizes investigated. The variance–
covariance matrix is
Var½A1;A2 ¼ SNn þ
SD
m
ðA8Þ
where SN and SD represent the estimated variance–covariance
matrices of the paired pseudo-values in the nondiseased and
diseased groups, respectively. Therefore,
VarðA1;A2Þ ¼ VarðA1Þ þ VarðA2Þ  2CovðA1;A2Þ ðA9Þ
where each variance and each covariance is a sum of the
corresponding components from SN/n and SD/m.
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